Jongkundang has ranked among the top searched stocks on 3 days within the past month.


As of 2:31 PM on the 2nd, Jongkundang is trading at 179,500 KRW, down 3.49% from the previous day. This represents a 14.73% decline compared to August 20. Jongkundang is known as a leading pharmaceutical company in the industry, focusing on therapeutics.

Over the past 5 days, individual investors have net purchased 55,178 shares, while foreigners and institutions have net sold 7,047 shares and 54,795 shares, respectively.


On August 31, Jongkundang was a market topic with the news of entering Phase 3 clinical trials for Nafamostat, a COVID-19 treatment...



※Source: AI Investment Assistant AI Rasero


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing